Study of the automated synthesis of the radiopharmaceutical fluoroestradiol-18F

Approximately 75% of breast cancer cells express estrogen receptor positive, being the second leading cause of cancer death among women worldwide with an incidence of 25% per year. 16α-[18F]-fluoro-17β-estradiol, FES-18F, is a radiopharmaceutical that binds to estrogen receptors enabling the acquisi...

Full description

Saved in:
Bibliographic Details
Main Authors: Luiza Mascarenhas Balieiro, Henrique Barcellos de Oliveira, Luiz Felipe Teixeira Silva, Maria Helena Bellini, Margareth Mie Nakamura Matsuda, Elaine Bortoleti de Araujo
Format: Article
Language:English
Published: Brazilian Radiation Protection Society (Sociedade Brasileira de Proteção Radiológica, SBPR) 2021-09-01
Series:Brazilian Journal of Radiation Sciences
Subjects:
Online Access:https://bjrs.org.br/revista/index.php/REVISTA/article/view/1709
Tags: Add Tag
No Tags, Be the first to tag this record!